Angiodynamics Inc Income Statement

Income Statement May2009 May2010 May2011 May2012 May2013 May2014 May2015 May2016 May2017 May2018 May2019 May2020 May2021 May2022 May2023 May2024 May2025
Revenue & cost
Revenue 195.05M216.03M215.62M221.92M341.92M354.43M356.53M353.89M269.79M261.65M270.63M264.16M291.01M316.22M338.75M303.91M292.50M
Cost of Revenue 74.99M89.07M90.05M65.76M77.56M174.25M180.74M179.57M125.84M117.80M114.63M113.89M134.22M150.49M164.51M149.22M134.79M
Gross Profit 120.06M126.97M125.57M125.31M168.51M180.17M175.80M174.32M143.95M143.86M156.00M150.27M156.79M165.73M174.25M154.70M157.71M
Operating items
Amortization - Intangibles 9.13M9.46M9.23M9.39M16.60M16.60M18.00M18.00M14.60M13.91M17.10M18.12M18.14M19.50M18.80M13.05M10.32M
Research & Development 17.91M19.27M21.37M20.51M26.09M28.12M26.59M25.05M24.15M24.34M28.26M29.68M36.39M30.74M29.88M31.51M26.22M
Selling, General & Administrative 19.12M16.44M17.83M19.03M26.04M26.90M30.03M30.58M31.13M30.99M34.90M37.87M35.92M38.45M40.00M41.16M42.09M
Restructuring Costs 15.86M13.80M10.87M26.26M12.59M27.51M15.43M15.13M6.01M20.23M9.04M15.63M53.18M15.62M
Other Operating Expenses 66.92M70.39M74.47M75.15M97.35M103.79M96.29M104.94M72.33M87.27M87.11M243.80M99.53M115.97M139.91M54.50M113.72M
Operating Expenses 103.96M106.10M113.67M130.55M163.27M169.69M179.25M173.30M155.12M158.03M165.40M317.37M192.07M194.20M225.43M401.63M197.66M
Operating Income 16.10M20.87M11.90M-5.24M5.24M10.49M-3.45M1.02M-11.18M-14.17M-9.40M-167.10M-35.28M-28.47M-51.18M-192.44M-39.95M
EBIT 16.10M20.87M11.90M-5.24M5.24M10.49M-3.45M1.02M-11.18M-14.17M-9.40M-167.10M-35.28M-28.47M-51.18M-192.44M-39.95M
Non-operating items
Interest & Investment Income 1.56M0.71M0.74M1.09M0.10M0.00M0.01M-2.70M1.61M0.98M
Other Non Operating Income -1.26M-0.41M-6.58M-5.30M-4.68M-4.27M-3.12M-3.09M-0.21M-0.13M0.09M-0.79M-0.55M-0.82M4.94M
Non Operating Income -1.26M-0.41M-6.58M-5.30M-4.68M-4.27M-3.12M-3.09M-5.31M-1.04M-0.77M-1.48M-3.26M-0.82M5.92M
Net income details
EBT 15.15M19.62M10.64M-5.65M-1.34M5.19M-8.13M-3.25M-14.29M-17.26M-14.70M-168.13M-36.05M-29.95M-54.44M-191.64M-34.03M
Tax Provisions 4.27M7.31M2.56M-0.32M-0.29M2.84M-4.74M40.34M-7.24M-11.04M-3.56M-1.35M-4.50M-3.40M-2.00M-7.29M-0.04M
Profit After Tax 9.93M12.31M8.08M-5.33M-1.05M2.35M-3.39M-43.59M-7.05M16.34M61.34M-166.79M-31.55M-26.55M-52.44M-184.35M-33.99M
Income from Continuing Operations 10.88M12.31M8.08M-5.33M-1.05M2.35M-3.39M-43.59M-7.05M-6.23M-11.15M-166.79M-31.55M-26.55M-52.44M-184.35M-33.99M
Consolidated Net Income 10.88M12.31M8.08M-5.33M-1.05M2.35M-3.39M-43.59M12.06M22.56M72.49M-166.79M-31.55M-26.55M-52.44M-184.35M-33.99M
Income towards Parent Company 10.88M12.31M8.08M-5.33M-1.05M2.35M-3.39M-43.59M12.06M22.56M72.49M-166.79M-31.55M-26.55M-52.44M-184.35M-33.99M
Net Income towards Common Stockholders 10.88M12.31M8.08M-5.33M-1.05M2.35M-3.39M-43.59M12.06M22.56M72.49M-166.79M-31.55M-26.55M-52.44M-184.35M-33.99M
Additional items
EPS (Basic) 0.450.500.32-0.20-0.030.07-0.09-1.21-0.190.441.64-4.39-0.82-0.68-1.33-4.59-0.83
EPS (Weighted Average and Diluted) 0.440.500.32-0.20-0.030.07-0.09-1.21-0.190.441.64-4.39-0.82-0.68-1.33-4.59-0.83
Shares Outstanding (Weighted Average) 24.43M24.73M24.98M25.20M35.05M35.42M35.92M36.37M36.78M36.80M37.28M37.87M38.14M38.78M39.24M40.05M40.61M
Shares Outstanding (Diluted Average) 24.51M24.79M25.13M25.38M34.82M35.44M35.68M36.16M36.62M37.08M37.48M37.96M38.34M39.01M39.48M40.18M40.85M
EBITDA 16.10M20.87M11.90M-5.24M5.24M10.49M-3.45M1.02M-11.18M-14.17M-9.40M-167.10M-35.28M-28.47M-51.18M-192.44M-39.95M
Interest Expenses -0.73M-0.67M-0.50M0.99M1.41M3.66M3.19M3.38M2.84M3.06M5.10M0.91M0.86M0.69M2.70M-1.61M
Tax Rate 28.16%37.24%24.06%5.70%21.39%54.74%58.33%50.67%63.93%24.19%0.80%12.49%11.36%3.66%3.80%0.11%